SAMJIN PHARMACEUTICAL CO.,LTD (삼진제약(주))
KOSPI Stock Code: 005500 | DART Corp Code: 00128412
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | SAMJIN PHARMACEUTICAL CO.,LTD |
|---|---|
| Korean legal name | 삼진제약(주) |
| Alternate names | 삼진제약 |
| Market | KOSPI |
| Stock Code | 005500 |
| DART Corp Code | 00128412 |
| CEO | 최지현, 조규석 |
| Business Registration No. | 1058100769 |
| Corporate Registration No. | 1101110088652 |
| Established Date | 1968-04-18 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 서울특별시 마포구 와우산로 121 삼진제약사옥 |
| Homepage | https://www.samjinpharm.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316001338 |
| verified_at | 2026-11-01T02:17:44.544Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: OFS (Separate) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316001338
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 309,133,530,719 | KRW 308,349,934,442 |
| Operating Income (영업이익) | KRW 26,784,499,637 | KRW 31,637,502,800 |
| Net Income (당기순이익) | KRW 24,169,889,943 | KRW 39,232,983,400 |
| Total Assets (자산총계) | KRW 470,531,747,766 | KRW 425,166,281,599 |
| Total Liabilities (부채총계) | KRW 180,137,009,017 | KRW 163,511,213,621 |
| Total Equity (자본총계) | KRW 290,394,738,749 | KRW 261,655,067,978 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-09-02 | 20260902000298 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 최영조 |
2026-09-02 | 20260902000292 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 최지현 |
2026-08-25 | 20260825000416 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 최지선 |
2026-08-25 | 20260825000411 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 최지현 |
2026-08-25 | 20260825000408 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 최승주 |
2026-08-25 | 20260825000402 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 최지현 |
2026-08-25 | 20260825000395 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 최승주 |
2026-08-14 | 20260814003494 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 삼진제약 |
2026-08-10 | 20260810000641 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 조규형 |
2026-08-10 | 20260810000630 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 조규석 |
2026-08-10 | 20260810000624 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 조의환 |
2026-08-10 | 20260810000617 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 조의환 |
2026-08-10 | 20260810800626 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 삼진제약 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316001338 | verified_at: 2026-11-01T02:17:44.544Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.